Individualized Treatments in Adults With Relapsed/Refractory Cancers

Clinical trial NCT06024603 · COMPLETED

Trial details

NCT number: NCT06024603
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Refractory Cancer Relapsed Cancer

Start date: 2023-11-20
Primary completion: 2025-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.